Auteur P. VICKERMAN

  Tris disponibles Ajouter le résultat à votre sélection

  Affiner la recherche

Overdose prevention centres, safe consumption sites, and drug consumption rooms: A rapid evidence review

G. W. SHORTER ; P. E. MCKENNA-PLUMLEY ; K. B. D. CAMPBELL ; J. R. KEEMINK ; B. D. SCHER ; S. CUTTER ; Z. KHADJESARI ; A. STEVENS ; A. ARTENIE ; P. VICKERMAN ; P. BOLAND ; N. M. MILLER ; A. O. CAMPBELL | 2023
Rapport

This rapid review on overdose prevention centres (OPCs) aims to collate and summarise existing evidence. It describes the impact of OPCs on individuals who use drugs, communities, and public health. OPCs are community facilities which provide a [...]

Plus d'info

Ajouter à la sélection

Lien externe

Patterns of drug use among people who inject drugs: A global systematic review and meta-analysis

P. WEBB ; J. IRELAND ; S. COLLEDGE-FRISBY ; A. PEACOCK ; J. LEUNG ; P. VICKERMAN ; M. FARRELL ; M. HICKMAN ; J. GREBELY ; L. DEGENHARDT | 2024
Dans International Journal of Drug Policy (Vol.128, June 2024) Article : Périodique

Background: A better understanding of global patterns of drug use among people who inject drugs can inform interventions to reduce harms related to different use profiles. This review aimed to comprehensively present the geographical variation i[...]

Plus d'info

Ajouter à la sélection

Lien externe

Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis

L. PLATT ; P. EASTERBROOK ; E. GOWER ; B. MCDONALD ; K. SABIN ; C. McGOWAN ; I. YANNY ; H. RAZAVI ; P. VICKERMAN | 2016
Dans Lancet Infectious Diseases (The) (Vol.16, n°7, July 2016) Article : Périodique

Background: At global level, there are 37 million people infected with HIV and 115 million people with antibodies to hepatitis C virus (HCV). Little is known about the extent of HIV-HCV co-infection. We sought to characterise the epidemiology an[...]

Plus d'info

Ajouter à la sélection

Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed. HIV in people who use drugs 2

L. DEGENHARDT ; B. MATHERS ; P. VICKERMAN ; T. RHODES ; C. LATKIN ; M. HICKMAN | 2010
Dans Lancet (The) (Vol.376, n°9737, Jul 24, 2010) Article : Périodique

HIV can spread rapidly between people who inject drugs (through injections and sexual transmission), and potentially the virus can pass to the wider community (by sexual transmission). Here, we summarise evidence on the effectiveness of individu[...]

Plus d'info

Ajouter à la sélection

Public health and international drug policy

J. CSETE ; A. KAMARULZAMAN ; M. KAZATCHKINE ; F. ALTICE ; M. BALICKI ; J. BUXTON ; J. CEPEDA ; M. COMFORT ; E. GOOSBY ; J. GOULAO ; C. HART ; T. KERR ; A. M. LAJOUS ; S. LEWIS ; N. MARTIN ; D. MEJIA ; A. CAMACHO ; D. MATHIESON ; I. OBOT ; A. OGUNROMBI ; S. SHERMAN ; J. STONE ; N. VALLATH ; P. VICKERMAN ; T. ZABRANSKY ; C. BEYRER | 2016
Dans Lancet (The) (Vol.387, n°10026, April 2, 2016) Article : Périodique

ENGLISH: In September, 2015, the member states of the UN endorsed Sustainable Development Goals (SDGs) for 2030, which aspire to human-rights-centred approaches to ensuring the health and wellbeing of all people. The SDGs embody both the UN Cha[...]

Plus d'info

Ajouter à la sélection

Respondent driven sampling and community structure in a population of injecting drug users, Bristol, UK

H. L. MILLS ; C. COLIJN ; P. VICKERMAN ; D. LESLIE ; V. HOPE ; M. HICKMAN | 2012
Dans Drug and Alcohol Dependence (Vol.126, n°3, December 2012) Article : Périodique

Background: A 2006 respondent driven sampling (RDS) survey of injecting drug users (IDUs) in Bristol, UK, estimated 40 per 100 person years HCV incidence but in 2009 another RDS survey estimated only 10 per 100 person years incidence amongst the[...]

Plus d'info

Ajouter à la sélection

Risk of death during and after opiate substitution treatment in primary care: prospective observational study in UK General Practice Research Database

R. CORNISH ; J. MACLEOD ; J. STRANG ; P. VICKERMAN ; M. HICKMAN | 2010
Dans British Medical Journal (Vol.341, n°7779, 30 October 2010) Article : Périodique

Objective To investigate the effect of opiate substitution treatment at the beginning and end of treatment and according to duration of treatment. Design Prospective cohort study. Setting UK General Practice Research Database Participants Pri[...]

Plus d'info

Ajouter à la sélection

Scaling-up HCV prevention and treatment interventions in rural United States - model projections for tackling an increasing epidemic

H. FRASER ; J. ZIBBELL ; T. HOERGER ; S. HARIRI ; C. VELLOZZI ; N. K. MARTIN ; A. H. KRAL ; M. HICKMAN ; J. W. WARD ; P. VICKERMAN | 2018
Dans Addiction (Vol.113, n°1, January 2018) Article : Périodique

Background and aims: Effective strategies are needed to address dramatic increases in hepatitis C virus (HCV) infection among people who inject drugs (PWID) in rural settings of the United States. We determined the required scale-up of HCV treat[...]

Plus d'info

Ajouter à la sélection

The cost-effectiveness of HIV preventive measures among injecting drug users in Svetlogorsk, Belarus

KUMARANAYAKE L. ; P. VICKERMAN ; D. WALKER ; SAMOSHKIN S. ; ROMANTZOV V. ; EMELYANOVA Z. ; ZVIAGIN V. ; C. WATTS | 2004
Périodique

ENGLISH : Aim. To undertake a cost-effectiveness analysis of a harm reduction and HIV prevention project for injecting drug users (IDUs) in Eastern Europe. Economic evaluation methods were adapted to consider the effect of an 8-month financing[...]

Plus d'info

Ajouter à la sélection

The global epidemiology of injecting drug use, HIV, viral hepatitis and tuberculosis among people who are incarcerated: a multistage systematic review

L. DEGENHARDT ; M. HICKMAN ; F. L. ALTICE ; J. GREBELY ; S. TAYLOR ; M. LYNCH ; A. KAMENJAS ; J. MARSDEN ; L. T. TRAN ; P. WEBB ; O. PRICE ; C. MACDONALD ; F. A. DA COSTA ; J. BERK ; A. BUSSE ; E. CUNNINGHAM ; C. DANIELS ; B. HAJARIZADEH ; L. MONTANARI ; L. ROYUELA ; K. SABIN ; J. STONE ; A. VERSTER ; P. VICKERMAN ; M. FARRELL ; T. SANTO | 2026
Dans International Journal of Drug Policy (Vol.150, April 2026) Article : Périodique

Background: This global systematic review assesses the prevalence of injecting drug use (IDU) and key infectious diseases (HIV, hepatitis C virus [HCV], tuberculosis and hepatitis B virus [HBV]) among people who are incarcerated. Methods: We co[...]

Plus d'info

Ajouter à la sélection

Lien externe

The impact of buprenorphine and methadone on mortality: a primary care cohort study in the United Kingdom

M. HICKMAN ; C. STEER ; K. TILLING ; A. G. LIM ; J. MARSDEN ; T. MILLAR ; J. STRANG ; M. TELFER ; P. VICKERMAN ; J. MACLEOD | 2018
Dans Addiction (Vol.113, n°8, August 2018) Article : Périodique

AIMS: To estimate whether opioid substitution treatment (OST) with buprenorphine or methadone is associated with a greater reduction in the risk of all-cause mortality (ACM) and opioid drug-related poisoning (DRP) mortality. DESIGN: Cohort stud[...]

Plus d'info

Ajouter à la sélection

Lien externe

The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence

K. M. E. TURNER ; S. HUTCHINSON ; P. VICKERMAN ; V. HOPE ; N. CRAINE ; N. E. PALMATEER ; M. MAY ; A. TAYLOR ; D. DE ANGELIS ; S. CAMERON ; J. PARRY ; M. LYONS ; D. GOLDBERG ; E. ALLEN ; M. HICKMAN | 2011
Dans Addiction (Vol.106, n°11, November 2011) Article : Périodique

AIMS To investigate whether opiate substitution therapy (OST) and needle and syringe programmes (NSP) can reduce hepatitis C virus (HCV) transmission among injecting drug users (IDUs). DESIGN Meta-analysis and pooled analysis, with logistic re[...]

Plus d'info

Ajouter à la sélection

Lien externe

The prevalence of non-fatal overdose among people who inject drugs: A multi-stage systematic review and meta-analysis

S. COLLEDGE ; A. PEACOCK ; J. LEUNG ; S. LARNEY ; J. GREBELY ; M. HICKMAN ; E. CUNNINGHAM ; A. TRICKEY ; J. STONE ; P. VICKERMAN ; L. DEGENHARDT | 2019
Dans International Journal of Drug Policy (Vol.73, November 2019) Article : Périodique

Background: People who inject drugs (PWID) are at an elevated risk of fatal overdose in the first year after experiencing a non-fatal event. Such non-fatal events may also result in overdose-related sequelae, ranging from physical injury to para[...]

Plus d'info

Ajouter à la sélection

Nouveauté

Treatment and primary prevention in people who inject drugs for chronic hepatitis C infection: is elimination possible in a high-prevalence setting?

I. GOUNTAS ; V. SYPSA ; O. ANAGNOSTOU ; N. MARTIN ; P. VICKERMAN ; E. KAFETZOPOULOS ; A. HATZAKIS | 2017
Dans Addiction (Vol.112, n°7, July 2017) Article : Périodique

Aims: To project the impact of scaling-up oral anti-viral therapy and harm reduction on chronic hepatitis C (CHC) prevalence and incidence among people who inject drugs (PWID) in Greece, to estimate the relationship between required treatment le[...]

Plus d'info

Ajouter à la sélection

Univariable associations between a history of incarceration and HIV and HCV prevalence among people who inject drugs across 17 countries in Europe 2006 to 2020 - is the precautionary principle applicable?

L. WIESSING ; E. KALAMARA ; J. STONE ; P. ALTAN ; L. VAN BAELEN ; A. FOTIOU ; D. GARCIA ; J. GOULAO ; B. GUARITA ; V. HOPE ; M. JAUFFRET-ROUSTIDE ; L. JURGELAITIENE ; M. KABERG ; A. KAMARULZAMAN ; L. LEMSALU ; A. KIVITE-URTANE ; B. KOLARIC ; L. MONTANARI ; M. ROSINSKA ; L. SAVA ; I. HORVATH ; T. SEYLER ; V. SYPSA ; A. TARJAN ; I. YIASEMI ; R. ZIMMERMANN ; M. FERRI ; K. DOLAN ; A. UUSKULA ; P. VICKERMAN | 2021
Dans Eurosurveillance (Vol.26, n°49, 09 Decembe 2021) Article : Périodique

Background: People who inject drugs (PWID) are frequently incarcerated, which is associated with multiple negative health outcomes. Aim: We aimed to estimate the associations between a history of incarceration and prevalence of HIV and HCV infe[...]

Plus d'info

Ajouter à la sélection

Lien externe